Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian G Barr

Showing results (51-60 of 190) with videos related to

Pageof 19
Sort By:
Vaccines|January 8, 2025
The Impact of Obesity on Influenza Vaccine Immunogenicity and Antibody Transfer to the Infant During PregnancyMichelle Clarke, Suja M Mathew, Lynne C Giles, et al.
Communicable Diseases Intelligence Quarterly Report|June 5, 2008
Higher than expected seasonal influenza activity in Victoria, 2007Emma R Miller, James E Fielding, Kristina A Grant, et al.
Virus Research|May 28, 2004
Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugsAeron C Hurt, Jennifer L McKimm-Breschkin, Mandy McDonald, et al.
Influenza and Other Respiratory Viruses|June 20, 2020
Comparative epidemiology, phylogenetics, and transmission patterns of severe influenza A/H3N2 in Australia from 2003 to 2017Jing Xia, Dillon C Adam, Aye Moa, et al.
Communicable Diseases Intelligence Quarterly Report|October 29, 2004
Surveillance for neuraminidase inhibitor resistance in human influenza viruses from AustraliaAeron C Hurt, Ian G Barr, Christopher J Durrant, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 23, 2013
The use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B virusesYi-Mo Deng, Pina Iannello, Natalie Caldwell, et al.
Vaccine|June 26, 2016
Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvantDavid L Gordon, Dimitar Sajkov, Yoshikazu Honda-Okubo, et al.
Influenza and Other Respiratory Viruses|December 15, 2015
Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling studyGeorge J Milne, Nilimesh Halder, Joel K Kelso, et al.
Communicable Diseases Intelligence Quarterly Report|January 2, 2010
High proportion of influenza B characterises the 2008 influenza season in VictoriaKristina A Grant, Kylie Carville, James E Fielding, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 27, 2015
Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoringKaren Little, Sook-Kwan Leang, Jeff Butler, et al.
Pageof 19

Showing results (51-60 of 190) with videos related to

Sort By:
Pageof 19
Vaccines|January 8, 2025
The Impact of Obesity on Influenza Vaccine Immunogenicity and Antibody Transfer to the Infant During PregnancyMichelle Clarke, Suja M Mathew, Lynne C Giles, et al.
Communicable Diseases Intelligence Quarterly Report|June 5, 2008
Higher than expected seasonal influenza activity in Victoria, 2007Emma R Miller, James E Fielding, Kristina A Grant, et al.
Virus Research|May 28, 2004
Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugsAeron C Hurt, Jennifer L McKimm-Breschkin, Mandy McDonald, et al.
Influenza and Other Respiratory Viruses|June 20, 2020
Comparative epidemiology, phylogenetics, and transmission patterns of severe influenza A/H3N2 in Australia from 2003 to 2017Jing Xia, Dillon C Adam, Aye Moa, et al.
Communicable Diseases Intelligence Quarterly Report|October 29, 2004
Surveillance for neuraminidase inhibitor resistance in human influenza viruses from AustraliaAeron C Hurt, Ian G Barr, Christopher J Durrant, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 23, 2013
The use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B virusesYi-Mo Deng, Pina Iannello, Natalie Caldwell, et al.
Vaccine|June 26, 2016
Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvantDavid L Gordon, Dimitar Sajkov, Yoshikazu Honda-Okubo, et al.
Influenza and Other Respiratory Viruses|December 15, 2015
Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling studyGeorge J Milne, Nilimesh Halder, Joel K Kelso, et al.
Communicable Diseases Intelligence Quarterly Report|January 2, 2010
High proportion of influenza B characterises the 2008 influenza season in VictoriaKristina A Grant, Kylie Carville, James E Fielding, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 27, 2015
Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoringKaren Little, Sook-Kwan Leang, Jeff Butler, et al.
Pageof 19